{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T07:12:35Z","timestamp":1792653155786,"version":"4.5.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.annder.2024.103288","type":"journal-article","created":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T08:44:21Z","timestamp":1721033061000},"page":"103288","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Health economic evaluation of topical treatments for external anogenital warts"],"prefix":"10.1016","volume":"151","author":[{"given":"H.","family":"Agbeci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Rollot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Derancourt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Q.","family":"Baglione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Benard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3962-8869","authenticated-orcid":false,"given":"A.","family":"Bertolotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.annder.2024.103288_b0005","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1086\/590560","article-title":"Human papillomavirus genotype distribution in external acuminata condylomata: a large French national study (EDiTH IV)","volume":"47","author":"Aubin","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.annder.2024.103288_b0010","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1471-2334-13-39","article-title":"Systematic review of the incidence and prevalence of genital warts","volume":"13","author":"Patel","year":"2013","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.annder.2024.103288_b0015","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1097\/01.olq.0000145851.76025.ad","article-title":"Rate and predictors of new genital warts claims and genital warts-related healthcare utilization among privately insured patients in the United States","volume":"31","author":"Koshiol","year":"2004","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.annder.2024.103288_b0020","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1097\/OLQ.0b013e3182215512","article-title":"The impact of anogenital warts on health-related quality of life: A 6-month prospective study","volume":"38","author":"Drolet","year":"2011","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.annder.2024.103288_b0025","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1136\/sti.2009.039982","article-title":"Loss of quality of life associated with genital warts: baseline analyses from a prospective study","volume":"87","author":"Senecal","year":"2011","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.annder.2024.103288_b0030","unstructured":"Anogenital warts - 2015 STD Treatment Guidelines. https:\/\/www.cdc.gov\/std\/treatment-guidelines\/anogenital-warts.htm. Accessed July 17,2021."},{"key":"10.1016\/j.annder.2024.103288_b0035","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1111\/jdv.16522","article-title":"2019 IUSTI-Europe guideline for the management of anogenital warts","volume":"34","author":"Gilson","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.annder.2024.103288_b0040","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.annder.2016.09.013","article-title":"External genital warts (condylomata)","volume":"143","author":"Bouscarat","year":"2016","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.annder.2024.103288_b0045","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1136\/sextrans-2011-050073","article-title":"The impact of genital warts: loss of quality of life and cost of treatment in eight sexual health clinics in the UK","volume":"87","author":"Woodhall","year":"2011","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.annder.2024.103288_b0050","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1136\/sti.2010.048421","article-title":"Genital warts and cost of care in England","volume":"87","author":"Desai","year":"2011","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.annder.2024.103288_b0055","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1007\/s40273-018-0691-9","article-title":"Medical care costs associated with genital warts for commercially insured US patients","volume":"36","author":"Dahlstrom","year":"2018","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.annder.2024.103288_b0060","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.gyobfe.2006.12.010","article-title":"Incidence, prise en charge et co\u00fbt des condylomes acumin\u00e9s anog\u00e9nitaux chez les femmes consultant leur gyn\u00e9cologue en France","volume":"35","author":"Monson\u00e9go","year":"2007","journal-title":"Gyn\u00e9cologie Obst\u00e9trique Fertil"},{"key":"10.1016\/j.annder.2024.103288_b0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta20240","article-title":"Clinical effectiveness and cost-effectiveness of interventions for the treatment of anogenital warts: systematic review and economic evaluation","volume":"20","author":"Thurgar","year":"2016","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.annder.2024.103288_b0070","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s13555-020-00357-z","article-title":"Local management of anogenital warts in non-immunocompromised adults: a network meta-analysis of randomized controlled trials","volume":"10","author":"Bertolotti","year":"2020","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.annder.2024.103288_b0075","first-page":"242","volume":"16","author":"Gross","year":"2018","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.annder.2024.103288_b0080","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.jaad.2019.03.080","article-title":"Methodologic gaps and risk of bias in randomized controlled trials of local anogenital wart treatments","volume":"81","author":"Bertolotti","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2024.103288_b0085","unstructured":"VIDAL\u202f: Base de donn\u00e9es m\u00e9dicamenteuse pour les prescripteurs lib\u00e9raux [Internet]. VIDAL. [cited 2020 Aug 11]. Available from: https:\/\/www.vidal.fr\/."},{"key":"10.1016\/j.annder.2024.103288_b0090","article-title":"5-FU for genital warts in non-immunocompromised individuals","author":"Batista","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.annder.2024.103288_b0095","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s13555-019-00328-z","article-title":"Local management of anogenital warts in non-immunocompromised adults: a systematic review and meta-analyses of randomized controlled trials","volume":"9","author":"Bertolotti","year":"2019","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.annder.2024.103288_b0100","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1365-4362.1996.tb03635.x","article-title":"The cost of treating genital warts","volume":"35","author":"Strauss","year":"1996","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.annder.2024.103288_b0105","doi-asserted-by":"crossref","first-page":"624","DOI":"10.21149\/10008","article-title":"Incidence, psychosocial burden, and economic impact of genital warts in Mexico","volume":"60","author":"Domenech-Vi\u00f1olas","year":"2018","journal-title":"Salud P\u00fablica M\u00e9xico"},{"key":"10.1016\/j.annder.2024.103288_b0110","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(19)30298-3","article-title":"Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis","volume":"394","author":"Drolet","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.annder.2024.103288_b0115","unstructured":"2014-02-03_Plan_cancer-2.pdf. Accessed September 7, 2020. https:\/\/solidarites-sante.gouv.fr\/IMG\/pdf\/2014-02-03_Plan_cancer-2.pdf."},{"key":"10.1016\/j.annder.2024.103288_b0120","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1741-7015-8-18","article-title":"CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials","volume":"24","author":"Schulz","year":"2010","journal-title":"BMC Med"}],"container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963824000449?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963824000449?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T22:42:52Z","timestamp":1726785772000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0151963824000449"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S0151963824000449"],"URL":"https:\/\/doi.org\/10.1016\/j.annder.2024.103288","relation":{},"ISSN":["0151-9638"],"issn-type":[{"value":"0151-9638","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Health economic evaluation of topical treatments for external anogenital warts","name":"articletitle","label":"Article Title"},{"value":"Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annder.2024.103288","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"103288"}}